发明名称 OLIGOMERIC COMPOUNDS FOR THE MODULATION OF HIF-1ALPHA EXPRESSION
摘要 Oligonucleotides directed against the hypoxia-inducible factor-1± (HIF-1±) gene are provided for modulating the expression of HIF-1±. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the HIF-1±. Methods of using these compounds for modulation of HIF-1± expression and for the treatment of diseases associated with the hypoxia-inducible factor-1± are provided. Examples of diseases are cancer and pre-eclampsia. The oligonucleotides may be composed of deoxyribonucleosides, a nucleic acid analogue, or Locked Nucleic Acid (LNA) or a combination thereof.
申请公布号 EP2264172(A1) 申请公布日期 2010.12.22
申请号 EP20100175232 申请日期 2003.04.04
申请人 SANTARIS PHARMA A/S 发明人 THRUE, CHARLOTTE;HØG, ANJA;KRISTJANSEN, PAUL
分类号 A61K45/06;C12N15/09;A61K31/70;A61K31/7088;A61K38/00;A61K48/00;A61P1/00;A61P3/00;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07H21/00;C07H21/04;C12N15/113 主分类号 A61K45/06
代理机构 代理人
主权项
地址
您可能感兴趣的专利